The Arthritis Foundation has been advocating for many years for the creation of a juvenile arthritis registry. A JA registry would improve the care children with arthritis receive. It would help pediatric rheumatologists make better decisions about the type of medications our children need and it could serve as an early warning system if there are unintended side effects or outcomes of JA therapies. The Arthritis Foundation testified last month at the Food and Drug Administration (FDA) recommending that such a registry be established: http://www.arthritis.org/murphy.phpNow it is your chance to let the FDA know we want them to continue their commendable work in this area and make our dream a reality - the creation of a fully funded JA registry that would help our kids! Please personalize your letter with your individual story and feel free to include some or the entire letter which can be downloaded here.
Please submit your comments either by regular mail or email by July 14th to: Division of Dockets Management(HFA-305), Food and Drug Administration5630 Fishers Lane, rm. 1061 Rockville, MD 20852
Or Submit electronic comments to http://www.regulations.gov/fdmspublic/component/main?main=SubmitComment&o=09000064809306d1
All comments should be identified with: Docket No. FDA-2009-N-0145
No comments:
Post a Comment